Skip to main content

Advertisement

Log in

Gallbladder Cancer, Treatment Failure and Relapses: the Peritoneum in Gallbladder Cancer

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

This study aims to review gallbladder cancer (GBC) and present current management strategies, factors influencing prognosis, recurrence and areas of consideration.

Methodology

Literature search in PubMed was made and restricted to articles published from 2002 to 2013 using the following keywords: (GBC + peritoneum and GBC + surgery + metastasis/recurrence); abstract evaluation narrowed results to 53 articles. Twenty-six single-institution reports with 2,097 patients among 36 large-scale retrospective studies were obtained and focused on surgical outcomes.

Results

GBC presents late and recurs early with a poor prognosis. There is no definitive time for curative re-resection following incidental diagnosis. Effective surgical strategies for each disease stage remain unclear. Management guidelines are not universally standardised, most institutions utilise protocols based on individual experiences and limitations. Early-stage GBC is curable with complete resection but invisible metastases at unobvious sites remain problematic. In this study, at least 450 patients relapsed, most had peritoneal metastasis. The peritoneum is a common metastatic site, its microenvironment is intrinsically hypoxic, well vascularized and lined with mesothelium overlaying immune aggregates, which express pro-angiogenic and adhesion molecules that are highly selective for tumour growth and evolution. There are no medical/molecular antagonists to inhibit peritoneal carcinomatosis. Peritonectomies have been successfully undertaken; furthermore, GBC responds to some chemotherapy combinations.

Conclusion

This review focused on GBC surgery. Peritoneal carcinomatosis is common. In carefully selected patients, the incorporation of peritoneal disease in cytoreductive surgery and intraperitoneal chemotherapy will inhibit a vehicle for dissemination, eliminate future relapse sites and improve survival. Areas for consideration include universally standardised protocols, clear management guidelines for each stage, effective re-resection timings with guidance on where or how to identify additional disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reid KM, Medina RD, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671–81.

    Article  PubMed  Google Scholar 

  2. Kai M, Chijiiwa K, Ohuchida J, et al. A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoima. J Gastrointest Surg. 2007;11:1025–32.

    Article  PubMed  Google Scholar 

  3. Downing SR, Cadogan KA, Ortega G, et al. Early-stage gallbladder cancer in the surveillance, epidemiology, and end results database. Arch Surg. 2011;146:734–8.

    Article  PubMed  Google Scholar 

  4. Yang X, Yang J, Li L, et al. Analysis of the relationships between clinicopatologic factors and survival in gallbladder cancer following surgical resection with curative intent. PLoS ONE. 2012;7:e51513.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Veleso MGP, Rodrigues DN. Gallbladder carcinoma: clinicopathological study of 24 cases. J Bras Patol Med Lab. 2011;47:439–44.

    Article  Google Scholar 

  6. Pavlidis TE, Pavlidis ET, Symeonidis NG, et al. Current curative surgical management of gallbladder cancer: a brief review. J Curr Surg. 2012;2:81–3.

    Google Scholar 

  7. Foster JM, Hoshi H, Gibbs JF, et al. Gallbladder cancer: defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol. 2007;14:833–40.

    Article  PubMed  Google Scholar 

  8. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology Hepatobiliary Cancers: Version 2.2012 NCCN.org http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

  9. Jensen EH, Abraham A, Habermann EB, et al. A critical analysis of the surgical; management of early-stage gallbladder in the United States. J Gastrointest Surg. 2009;13:722–7.

    Article  PubMed  Google Scholar 

  10. Shrikhande SV, Barreto SC. Surgery for gallbladder cancer: the need to generate greater evidence. World J Gastrointest Surg. 2009;1:26–9.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Coetze TO, Paolucci. Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc. 2010;24:2156–64.

    Article  Google Scholar 

  12. Lin HT, Liu GJ, Wu D, Lou JY. Metastasis of primary gallbladder carcinoma in lymph node and liver. World J Gastroenterol. 2005;11:748–51.

    PubMed  Google Scholar 

  13. Sikora SS, Singh RK. Surgical strategies in patients with gallbladder cancer: nihilism to option. J Surg Oncol. 2006;93:670–81.

    Article  PubMed  Google Scholar 

  14. Kokudo N, Makuuchi M, Natori T, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003;138:741–50. doi:10.1007/s12029-014-9597-8.

    Article  PubMed  Google Scholar 

  15. Shirai Y, Wakai T, Sakata J, Hatakeyama K. Regional lymphadenectomy for gallbladder cancer: rational extent, technical details, and patient outcomes. World J Gastroenterol. 2012;18:2775–83.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Lai CHE, Lau WY. Gallbladder cancer – a comprehensive review. Surgeon. 2008;6:101–10.

    Article  PubMed  Google Scholar 

  17. Shimizu H, Kimura F, Yoshidome H, et al. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. J Hepatobiliary Pancreat Surg. 2007;14:358–65.

    Article  PubMed  Google Scholar 

  18. Chan SY, Poon RTP, Lo CM, et al. Management of carcinoma of the gallbladder: a singleinstitution experience in 16 years. J Surg Oncol. 2008;97:156–64.

    Article  PubMed  Google Scholar 

  19. D’Hondt M, Lapointe R, Benamira Z, et al. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. Eur J Surg Oncol. 2013;39:548–53.

    Article  PubMed  Google Scholar 

  20. Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and uncertain future. Surg Oncol. 2012;21:e183–91.

    Article  CAS  PubMed  Google Scholar 

  21. Kim WS, Wook D, You DD, et al. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical for gallbladder carcinoma. J Gastrointest Surg. 2010;14:679–87.

    Article  PubMed  Google Scholar 

  22. Glockzin G, Schlitt HJ and Piso P: Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World Journal of Surgical Oncology 2009;7: OPEN ACCESS.

  23. Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg. 2007;11:1478–87.

    Article  PubMed  Google Scholar 

  24. Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15:168–81.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Chan KM, Yeh TS, Jan YY, Chen MF. Laparoscopic cholecystectomy for early gallbladder carcinoma: long-term outcome in comparison with conventional open cholecystectomy. Surg Endosc. 2006;20:1867–71.

    Article  CAS  PubMed  Google Scholar 

  26. Lee SE, Jang JY, Lim CS, et al. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol. 2011;17:174–80.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Cucinitta E, Lorenzini C, Melita G, et al. Incidental gall bladder carcinoma: does the surgical approach influence the outcome? ANZ J Surg. 2005;75:795–8.

    Article  Google Scholar 

  28. Murakami Y, Uemura K, Sudo T, et al. Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection. J Gastrointest Surg. 2011;15:1007–16.

    Article  PubMed  Google Scholar 

  29. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–81.

    Article  CAS  PubMed  Google Scholar 

  30. Pilgrim CHC, Groeschl RT, Quebbeman EJ, Gamblin TC. Recent advances in systemic therapies and radiotherapy for gallbladder cancer. Surg Oncol. 2013;22:61–7.

    Article  Google Scholar 

  31. Liang JW, Dong SX, Zhou ZX, et al. Surgical management for carcinoma of the gallbladder: a single-institution experience in 25 years. Chin Med J. 2008;121:1900–5.

    PubMed  Google Scholar 

  32. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthemia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol. 2003;21:799–806.

    Article  CAS  PubMed  Google Scholar 

  33. Sugarbaker P. Overview of peritoneal carcinomatosis. Cancerologia. 2008;3:119–24.

    Google Scholar 

  34. Sugarbaker PH. Cytoreductive surgery using peritonectomy and visceral resections for peritoneal surface malignancy. Transl Gastrointest Cancer. 2013;2:54–74.

    Google Scholar 

  35. Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma. Cancer. 2003;98:1689–700.

    Article  PubMed  Google Scholar 

  36. Nishio H, Nagino M, Ebata T, et al. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg. 2007;14:351–7.

    Article  PubMed  Google Scholar 

  37. Ouchi K, Mikuni J, Kakugawa Y. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg. 2002;9:256–60.

    Article  PubMed  Google Scholar 

  38. Choi BG, Kim CY, Cho SH, et al. Impact of lymph node ratio as a valuable prognostic fctor in gallbladder carcinoma, focusing on stage IIIb gallbladder carcinoma. J Korean Surg Soc. 2013;84:168–77.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Yamamoto H, Hayakawa N, Kitagawa Y, et al. Unsuspected gallbladder carcinoma after laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg. 2005;12:391–8.

    Article  PubMed  Google Scholar 

  40. Vazquez VDL, Sugarbaker P. Cholecystectomy, lesser omentectomy, and stripping of the omental bursa: a peritonectomy procedure. J Surg Oncol. 2003;84:45–9.

    Article  Google Scholar 

  41. Gerber SA, Rybalko VY, Bigelow CE, et al. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Ame J Pathol. 2006;169:1739–52.

    Article  CAS  Google Scholar 

  42. Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers. Surg Endosc. 2006;20:721–5.

    Article  CAS  PubMed  Google Scholar 

  43. Kim MC, Kim KH, Jung GJ, Rattner DW. Comparative study of complete and partial omentectomy in radical subtotal gastrectomy for early gastric cancer. Yonsei Med J. 2011;52:961–6.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Yi X, Long X, Zai H, et al. Unsuspected gallbladder carcinoma discovered during or after cholecystectomy: focus on appropriate radical re-resection according to the T-stage. Clin Trans Oncol. 2013. doi:10.1007/s12094-012-0988-7.

    Google Scholar 

  45. Rodriguez Otero JC, Proske A, Vallilengua C, et al. Gallbladder cancer: surgical results after cholecystectomy in 25 patients with lamina propria invasion and 26 patients with muscular layer invasion. J Hepatobiliary Pancreat Surg. 2006;13:562–6.

    Article  Google Scholar 

  46. Mebius RE. Lymphoid organs for peritoneal cavity immune response:milky spots. Immunity. 2009;30:670–2.

    Article  CAS  PubMed  Google Scholar 

  47. Oosterling SJ, van der Bij GJ, Bogels M, et al. Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimally residual disease. Cancer Immunol Immunother. 2006;55:1043–51.

    Article  CAS  PubMed  Google Scholar 

  48. Sorensen EW, Gerber SA, Sedlacek AL, et al. Omental immune aggregates and tumour metastasis within the peritoneal cavity. Immunol Res. 2009;45:185–94.

    Article  CAS  PubMed  Google Scholar 

  49. Silecchia G, Raparelli L, Navalon JMJ, et al. Laparoscopic cholecystectomy and incidental carcinoma of the extrahepatic biliary tree. J Soc Laparoendosc Surg. 2002;6:339–44.

    Google Scholar 

  50. Ito H, Matros E, Brooks DC, et al. Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg. 2004;8:183–90.

    Article  PubMed  Google Scholar 

  51. Yagi H, Shimazu M, Kawachi S, et al. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Heopatobiliary Pancreat Surg. 2006;13:530–6.

    Article  Google Scholar 

  52. Lin MY, Liu WY, Tolan AM, et al. Preoperative serum albumin but not prealbumin is an excellent predictor of postoperative complications and mortality in patients with gastrointestinal cancer. Am Surg. 2011;77:1286–9.

    PubMed  Google Scholar 

  53. Park JS, Yoon DS, Kim KS, et al. Actual recurrence patterns and risk factors influencing recurrence after curative resection with stage II gallbladder carcinoma. J Gastrointest Surg. 2007;11:631–7.

    Article  PubMed  Google Scholar 

  54. Kim JH, Kim WK, Kim JH, et al. Unsuspected gallbladder cancer diagnosed after laparoscopic cholecystectomy: focus on acute cholecystitis. World J Surg. 2010;34:114–20.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

I thank Dr Ian Beales (Norfolk and Norwich University Hospital) for helpful discussions.

Conflict of Interest

The author declares that she has no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charlotte Maplanka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maplanka, C. Gallbladder Cancer, Treatment Failure and Relapses: the Peritoneum in Gallbladder Cancer. J Gastrointest Canc 45, 245–255 (2014). https://doi.org/10.1007/s12029-014-9597-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-014-9597-8

Keywords

Navigation